Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds
US11365185B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2018 |
| Grant date | Jun 21, 2022 |
| Priority date | — |
| Expiry date | Nov 19, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I) or a pharmaceutical salt thereof, use, methods for its preparation are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.